In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


StemPar Sciences Inc.

Latest From StemPar Sciences Inc.

Recent Tech Transfer Deals, February 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Tech Transfers Between Academia And Industry column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Pharmaceuticals, and Medical Devices sectors.

BioPharmaceutical Medical Device

Out Of The Blocks, January 2013

Brief profiles of these recently formed companies: Guided Interventions, NeRRE Therapeutics, Silicon Valley Biosystems, Solstice Biologics, StemPar Sciences, and Stimwave Technologies.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • StemPar Sciences Inc.
  • Senior Management
  • Barry Sherman, MD, Pres. & CEO
    John Schembri, VP, CFO
  • Contact Info
  • StemPar Sciences Inc.
    Palo Alto, CA